CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 681.8	$ 678.3
Short-term investments	50.0	6.6
Accounts receivable, net	335.3	362.2
Inventories	692.3	577.2
Other current assets	165.6	172.0
Total current assets	1,925.0	1,796.3
Property, plant and equipment, net	395.5	306.1
Goodwill	320.4	293.0
Intangible assets, net	229.1	233.2
Operating lease assets	67.4	65.6
Deferred tax assets	72.0	60.5
Other long-term assets	39.6	16.8
Total assets	3,049.0	2,771.5
Current liabilities:
Current portion of long-term debt	2.2	0.5
Accounts payable	134.6	118.4
Customer advances	189.2	137.9
Other current liabilities	465.9	388.8
Total current liabilities	791.9	645.6
Long-term debt	842.3	812.8
Long-term deferred revenue	50.9	42.8
Deferred tax liabilities	43.1	48.8
Operating lease liabilities	47.0	47.0
Accrued pension	123.4	122.4
Other long-term liabilities	176.1	113.9
Commitments and contingencies (Note 17)
Redeemable noncontrolling interest		21.1
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2020 and 2019
Common stock, $0.01 par value 260,000,000 shares authorized, 174,045,610 and 173,502,375 shares issued and 151,987,081 and 154,155,798 outstanding at December 31, 2020 and 2019, respectively	1.7	1.7
Treasury stock at cost, 22,058,529 and 19,346,577 shares at December 31, 2020 and 2019, respectively	(667.0)	(543.8)
Additional paid-in capital	216.3	199.7
Retained earnings	1,406.5	1,274.7
Accumulated other comprehensive (loss) income	3.7	(25.5)
Total shareholders' equity attributable to Bruker Corporation	961.2	906.8
Noncontrolling interest in consolidated subsidiaries	13.1	10.3
Total shareholders' equity	974.3	917.1
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 3,049.0	$ 2,771.5